Invivyd (IVVD) Earnings Date & Reports

Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

IVVD is expected to report earnings to fall 57.65% to -21 cents per share on March 27

Q4'24

Est.

$-0.22

Q3'24

Missed

by $0.18

Q2'24

Missed

by $0.03

Q1'24

Beat

by $0.05

Q4'23

Missed

by $0.24

The last earnings report on November 14 showed earnings per share of -50 cents, missing the estimate of -33 cents. With 7.36M shares outstanding, the current market capitalization sits at 138.75M.

View a ticker or compare two or three

Compare

IVVD